Premium
Antipsychotic‐induced weight gain
Author(s) -
Goudie A. J.,
Cooper G. D.,
Halford J. C. G.
Publication year - 2005
Publication title -
diabetes, obesity and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.445
H-Index - 128
eISSN - 1463-1326
pISSN - 1462-8902
DOI - 10.1111/j.1463-1326.2004.00413.x
Subject(s) - weight gain , antipsychotic , antipsychotic drug , atypical antipsychotic , medicine , drug , adverse effect , drug development , pharmacology , psychology , schizophrenia (object oriented programming) , neuroscience , intensive care medicine , psychiatry , body weight
Novel ‘atypical’ antipsychotic drugs represent a substantial improvement on older ‘typical’ drugs. However, clinical experience has shown that some, but not all, of these drugs can induce substantial weight gain. This interferes with compliance with drug taking and has expected effects on morbidity and mortality. In this review, we summarize current thinking on: (i) the extent to which different ‘atypical’ drugs induce weight gain; (ii) the possible roles of various neurotransmitters and neuropeptides in this adverse drug reaction; and (iii) the state of development of animal models in this area. We also outline major areas for future research.